Showing results (31-40 of 45) with videos related to

Sort By:
Pageof 5
Cell Reports|June 14, 2018
Targeting EZH2 Reprograms Intratumoral Regulatory T Cells to Enhance Cancer ImmunityDavid Wang, Jason Quiros, Kelly Mahuron, et al.
Diabetes|June 26, 2018
Collateral Damage: Insulin-Dependent Diabetes Induced With Checkpoint InhibitorsAngeliki M Stamatouli, Zoe Quandt, Ana Luisa Perdigoto, et al.
Biorxiv : the Preprint Server for Biology|July 28, 2023
Non-coding sequence variation reveals fragility within interleukin 2 feedback circuitry and shapes autoimmune disease riskDimitre R Simeonov, Kyemyung Park, Jessica T Cortez, et al.
Elife|April 15, 2025
The extra-islet pancreas supports autoimmunity in human type 1 diabetesGraham L Barlow, Christian M Schürch, Salil S Bhate, et al.
Cancer Research|June 28, 2017
Targeting Adenosine in BRAF-Mutant Melanoma Reduces Tumor Growth and MetastasisArabella Young, Shin Foong Ngiow, Jason Madore, et al.
Journal of the Endocrine Society|March 2, 2023
Spectrum of Clinical Presentations, Imaging Findings, and HLA Types in Immune Checkpoint Inhibitor-Induced HypophysitisZoe Quandt, Stephanie Kim, Javier Villanueva-Meyer, et al.
Cancer Research|December 13, 2017
A2AR Adenosine Signaling Suppresses Natural Killer Cell Maturation in the Tumor MicroenvironmentArabella Young, Shin Foong Ngiow, Yulong Gao, et al.
Journal for Immunotherapy of Cancer|August 14, 2025
Autoimmune origin for immune checkpoint inhibitor-diabetes revealed by deep immune phenotyping of the pancreasZoe Quandt, Arabella Young, Graham Larson Barlow, et al.
Cancer Research|June 28, 2017
MAPK Signaling and Inflammation Link Melanoma Phenotype Switching to Induction of CD73 during ImmunotherapyJulia Reinhardt, Jennifer Landsberg, Jonathan L Schmid-Burgk, et al.
Pageof 5